Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.385 EUR
309.22 M EUR
1.78 B EUR
About Qiagen N.V.
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015002CX3
FIGI
BBG000S9C5D0
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RLT is 42.460 EUR — it has increased by 0.23% in the past 24 hours. Watch QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stocks are traded under the ticker 0RLT.
0RLT stock has fallen by −12.06% compared to the previous week, the month change is a −4.65% fall, over the last year QIAGEN NV ORD EUR0.01 (POST REV SPLIT) has showed a 1.78% increase.
We've gathered analysts' opinions on QIAGEN NV ORD EUR0.01 (POST REV SPLIT) future price: according to them, 0RLT price has a max estimate of 59.23 EUR and a min estimate of 44.42 EUR. Watch 0RLT chart and read a more detailed QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock forecast: see what analysts think of QIAGEN NV ORD EUR0.01 (POST REV SPLIT) and suggest that you do with its stocks.
0RLT reached its all-time high on Feb 9, 2021 with the price of 56.185 EUR, and its all-time low was 23.235 EUR and was reached on Oct 9, 2019. View more price dynamics on 0RLT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RLT stock is 2.64% volatile and has beta coefficient of 0.52. Track QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is QIAGEN NV ORD EUR0.01 (POST REV SPLIT) there?
Today QIAGEN NV ORD EUR0.01 (POST REV SPLIT) has the market capitalization of 9.14 B, it has decreased by −6.44% over the last week.
Yes, you can track QIAGEN NV ORD EUR0.01 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
QIAGEN NV ORD EUR0.01 (POST REV SPLIT) is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
0RLT earnings for the last quarter are 0.53 EUR per share, whereas the estimation was 0.50 EUR resulting in a 4.91% surprise. The estimated earnings for the next quarter are 0.60 EUR per share. See more details about QIAGEN NV ORD EUR0.01 (POST REV SPLIT) earnings.
QIAGEN NV ORD EUR0.01 (POST REV SPLIT) revenue for the last quarter amounts to 450.75 M EUR, despite the estimated figure of 441.16 M EUR. In the next quarter, revenue is expected to reach 503.29 M EUR.
0RLT net income for the last quarter is 88.07 M EUR, while the quarter before that showed −171.28 M EUR of net income which accounts for 151.42% change. Track more QIAGEN NV ORD EUR0.01 (POST REV SPLIT) financial stats to get the full picture.
QIAGEN NV ORD EUR0.01 (POST REV SPLIT) dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 30, 2025, the company has 5.97 K employees. See our rating of the largest employees — is QIAGEN NV ORD EUR0.01 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QIAGEN NV ORD EUR0.01 (POST REV SPLIT) EBITDA is 611.86 M EUR, and current EBITDA margin is 33.10%. See more stats in QIAGEN NV ORD EUR0.01 (POST REV SPLIT) financial statements.
Like other stocks, 0RLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QIAGEN NV ORD EUR0.01 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock shows the neutral signal. See more of QIAGEN NV ORD EUR0.01 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.